Condition
Pulmonary Hypertension Due to Lung Diseases clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Pulmonary Hypertension Due to Lung Diseases clinical trials that are recruiting, at sites in 2 countries (most in Austria (1), United States (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Collagen fingerprinting to stratify pulmonary hypertension in chronic lung disease
This project tests whether fragments of non-classical collagens in blood and lung tissue can help detect and sort pulmonary hypertension in people with COPD or pulmonary fibrosis.
-
Effects of Pioglitazone on Pulmonary Hypertension from Lung Disease
This study is testing if the medication Pioglitazone can help people with pulmonary hypertension caused by chronic lung disease feel better and improve their oxygen use.
Related topics
Quick answers
How many Pulmonary Hypertension Due to Lung Diseases clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Austria (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.